These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23432740)

  • 1. The impact of nurse-led education on haemodialysis patients' phosphate binder medication adherence.
    Sandlin K; Bennett PN; Ockerby C; Corradini AM
    J Ren Care; 2013 Mar; 39(1):12-8. PubMed ID: 23432740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventional study to improve adherence to phosphate binder treatment in dialysis patients.
    Hjemås BJ; Bøvre K; Mathiesen L; Lindstrøm JC; Bjerknes K
    BMC Nephrol; 2019 May; 20(1):178. PubMed ID: 31101020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic impact of improving phosphate binder therapy adherence and attainment of guideline phosphorus goals in hemodialysis patients: a Medicare cost-offset model.
    Ramakrishnan K; Braunhofer P; Newsome B; Lubeck D; Wang S; Deuson J; Claxton AJ
    Adv Ther; 2014 Dec; 31(12):1272-86. PubMed ID: 25479935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a nurse-led intensive educational programme on chronic kidney failure patients with hyperphosphataemia: randomised controlled trial.
    Shi YX; Fan XY; Han HJ; Wu QX; Di HJ; Hou YH; Zhao Y
    J Clin Nurs; 2013 Apr; 22(7-8):1189-97. PubMed ID: 23480506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietitian-led education program to improve phosphate control in a single-center hemodialysis population.
    Reddy V; Symes F; Sethi N; Scally AJ; Scott J; Mumtaz R; Stoves J
    J Ren Nutr; 2009 Jul; 19(4):314-20. PubMed ID: 19539185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication beliefs are associated with phosphate binder non-adherence in hyperphosphatemic haemodialysis patients.
    Wileman V; Farrington K; Wellsted D; Almond M; Davenport A; Chilcot J
    Br J Health Psychol; 2015 Sep; 20(3):563-78. PubMed ID: 25209368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nurse-led education and counselling to enhance adherence to phosphate binders.
    Van Camp YP; Huybrechts SA; Van Rompaey B; Elseviers MM
    J Clin Nurs; 2012 May; 21(9-10):1304-13. PubMed ID: 22151410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of therapeutic compliance in haemodialysis patients with poor phosphorus control and adherence to treatment with binders: COMQUELFOS study.
    Dolores Arenas M; Pérez-García R; Bennouna M; Blanco A; Mauricio O; Prados MD; Lerma JL; Luisa Muñiz M; Belén Martín M;
    Nefrologia; 2013; 33(2):196-203. PubMed ID: 23364580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients.
    Cervelli MJ; Shaman A; Meade A; Carroll R; McDonald SP
    Nephrology (Carlton); 2012 Jul; 17(5):458-65. PubMed ID: 22471559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to phosphate binder therapy is the primary determinant of hyperphosphatemia incidence in patients receiving peritoneal dialysis.
    Hung KY; Liao SC; Chen TH; Chao MC; Chen JB
    Ther Apher Dial; 2013 Feb; 17(1):72-7. PubMed ID: 23379497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to phosphate binders in hemodialysis patients: prevalence and determinants.
    Van Camp YP; Vrijens B; Abraham I; Van Rompaey B; Elseviers MM
    J Nephrol; 2014 Dec; 27(6):673-9. PubMed ID: 24563270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of phosphate binders in chronic kidney disease.
    Ketteler M; Biggar PH
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):413-20. PubMed ID: 23736841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing not to take phosphate binders: the role of dialysis patients' medication beliefs.
    Wileman V; Chilcot J; Norton S; Hughes L; Wellsted D; Farrington K
    Nephron Clin Pract; 2011; 119(3):c205-13. PubMed ID: 21832846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidisciplinary education approach to optimize phosphate control among hemodialysis patients.
    Chan MW; Cheah HM; Mohd Padzil MB
    Int J Clin Pharm; 2019 Oct; 41(5):1282-1289. PubMed ID: 31302884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RenaGel efficacy in severe secondary hyperparathyroidism.
    Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M
    Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional education for the management of osteodystrophy (nemo) in patients on haemodialysis: a randomised controlled trial.
    Karavetian M; Ghaddar S
    J Ren Care; 2013 Mar; 39(1):19-30. PubMed ID: 23176599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hyperphosphataemia: practices and perspectives amongst the renal care community.
    Nagel CJ; Casal MC; Lindley E; Rogers S; Pancířová J; Kernc J; Copley JB; Fouque D
    J Ren Care; 2014 Dec; 40(4):230-8. PubMed ID: 24814866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of gastric acid suppression with pantoprazole on the efficacy of sevelamer hydrochloride as a phosphate binder in haemodialysis patients: a pilot study.
    Lai B; Cervelli MJ
    Nephrology (Carlton); 2012 May; 17(4):402-6. PubMed ID: 22329674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of educational interventions with dialysis patient].
    Parmier M; Gourieux B; Krummel T; Bazin-Kara D; Dory A; Hannedouche T
    Nephrol Ther; 2016 Dec; 12(7):516-524. PubMed ID: 27776970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Education for dialysis patients lowers long-term phosphate levels and maintains health-related quality of life.
    Gardulf A; Pålsson M; Nicolay U;
    Clin Nephrol; 2011 Apr; 75(4):319-27. PubMed ID: 21426886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.